NASDAQ · Medical - Pharmaceuticals

DataMeds AI, Inc. (MEDS) Stock

$3.23 -5.06% NASDAQ: MEDS Healthcare

Valuation

MetricValue
Price$3.23
Market Cap$8.47M
P/E Ratio-0.08
P/B Ratio-0.49
P/S Ratio1.20
EPS (TTM)$-2.70
52-Week High$73.00
52-Week Low$0.82
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE877.58%
ROA-269.47%
ROCE867.20%
Gross Margin78.97%
Operating Margin-10071.06%
Net Margin-9.72%
Debt/Equity-1.67
Current Ratio1.70

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$11.0M$8.0M$0$432.0M
Operating Profit$-5.0M$-3.0M$-7.0M$-19.0M$-43.5B
Net Profit$-4.0M$-4.0M$-18.0M$9.0M$-42.0M
EPS$-7.58$-7.63$-7.49$2.48$-2.70
Op Margin-53.5%-24.1%-87.8%-13743.0%-10080.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$4.0M$13.0M$105.0M$84.2B
Total Liabilities$2.0M$3.0M$12.0M$26.0M$14.1B
Cash$3.0M$1.0M$0$0$6.7B
Borrowings$1.0M$2.0M$7.0M$3.0M$24.0M

Latest News

Wellgistics Health, Datavault AI Agree to Form DelivMeds AI MT Newswires · May 20, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-2.0M$-2.0M$-13.0M$-13.4B
Investing Cash Flow$0$-1.0M$0$28.0M$0
Financing Cash Flow$0$0$1.0M$2.0M$19.7B
Net Cash Flow$-3.0M$-2.0M$-1.0M$0$6.4B
Free Cash Flow$-3.0M$-2.0M$-2.0M$-13.0M$-13.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.71
FCF Yield-140.72%
Quick Ratio0.10
Interest Coverage-9.72
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Insiders Held68.38%
Institutions Held1.70%
Institutions Float Held5.36%
Institutional HolderSharesReport Date
Geode Capital Management, LLC14,2162026-03-31
Vanguard Capital Management LLC12,0852026-03-31
Vanguard Fiduciary Trust Co6,1922026-03-31
State Street Corporation2,4922026-03-31
Jane Street Group, LLC1,8802026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALGSAligos Therapeutics, Inc. $5.39 +1.41% -0.76 $33.32M 0.00%
BDSXBiodesix, Inc. $25.63 -2.99% -8.74 $208.64M 0.00%
BEATHeartbeam, Inc. $0.49 -10.00% -0.84 $27.13M 0.00%
INMBINmune Bio Inc. $1.83 -1.61% -2.81 $48.65M 0.00%
KZR $7.29 +0.00% -0.96 $53.86M 0.00%

About DataMeds AI, Inc.

DataMeds AI, Inc. is headquartered in US.

DataMeds AI, Inc. (MEDS) stock trades at $3.23 with a market capitalization of $8.47M. The stock is valued at a price-to-earnings (P/E) ratio of -0.08, price-to-book of -0.49, price-to-sales of 1.20. Over the past 52 weeks the stock has ranged between $0.82 and $73.00, and currently trades 95.6% below its 52-week high.

On profitability, DataMeds AI, Inc. generates a return on equity (ROE) of 877.58% — well above the market average, a sign of a high-quality business, return on capital employed of 867.20%, an operating margin of -10071.06%, a net profit margin of -9.72%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1171.00 +0.12% JNJ Johnson & Johnson $259.44 +1.15% ABBV AbbVie Inc. $275.16 +1.01% MRK Merck & Company, Inc. Common Stock (new) $144.72 +1.64% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.26 +0.89% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $654.06 +0.32% AMGN Amgen Inc. $411.01 +0.88% GILD Gilead Sciences, Inc. $148.75 +1.12% ABT Abbott Laboratories $99.36 +0.88% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides